Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (13)
  • p53
    (9)
  • MDM-2/p53
    (3)
  • DUB
    (2)
  • Ferroptosis
    (2)
  • Mdm2
    (2)
  • STAT
    (2)
  • Sirtuin
    (2)
  • Akt
    (1)
  • Others
    (25)
Filter
Search Result
Results for "

p53-dependent

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    56
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Natural Products
    10
    TargetMol | Natural_Products
  • Recombinant Protein
    13
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Cell Research
    1
    TargetMol | Inhibitors_Agonists
Naphthazarin
DHNQ, 5,8-Dihydroxy-1,4-naphthoquinone
T8678475-38-7
Naphthazarin (5,8-Dihydroxy-1,4-naphthoquinone) is effective by various cellular mechanisms including oxidative stress, activation of mitochondrial apoptosis-inducing factor (AIF), depolymerization of microtubules, interference with lysosomal function and p53-dependent p21 activation. It triggers apoptosis and has anti-tumor effects
  • Inquiry Price
Size
QTY
Lumichrome
7,8-Dimethylalloxazine
T50611086-80-2
Lumichrome is an endogenous compound in humans, produced by photodegradation of riboflavin. It utilizes a p53-dependent mechanism to inhibit growth and induce apoptosis in human lung cancer cells.
  • Inquiry Price
Size
QTY
TargetMol
Rubone
2'-Hydroxy-2,4,4',5,6'-pentamethoxychalcone
T2474473694-15-2
Rubone (2'-Hydroxy-2,4,4',5,6'-pentamethoxychalcone), a natural product and a modulator of miR-34a (microRNA-34), upregulates miR-34a expression in a p53-dependent manner, which in turn downregulates the expression of downstream targets Bcl-2, cyclin-D1, CDK6, SIRT1, and FOXP1, thereby inhibiting tumor growth and reversal of hepatocellular carcinoma (HCC) and chemoresistance in prostate cancer.
  • Inquiry Price
6-8 weeks
Size
QTY
Atractylenolide II
2-Atractylenolide, Asterolide
T5S016873069-14-4
1. Atractylenolide II (2-Atractylenolide) has antimelanoma effect by inhibiting STAT3 signalling. 2. Atractylenolide II has cytotoxic apoptotic effects may via p38 activation , ERK and Akt inactivation, p53 dependent.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Vitexin
Apigenin-8-C-glucoside
T6S13693681-93-4
1. Vitexin has antinociceptive and antispasmodic activities. 2. Vitexin exhibits a prominent first-pass effect. 3. Vitexin has antioxidant, antimyeloperoxidase, and α-glucosidase inhibitory activities. 4. Vitexin can either inhibit or induce activities of
  • Inquiry Price
Size
QTY
Protosappanin B
Q-100961, FT-0689654
T6S1780102036-29-3
1. Protosappanin B (Q-100961) significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43. 2. Protosappanin B induces the degradation of p53 protein, via activation of a MDM2-dependent ubiquitination process.
  • Inquiry Price
Size
QTY
EURYCOMANONE
Pasakbumin A
T702784633-29-4
Eurycomanone (Pasakbumin A) is cytotoxic on HepG2 cells by inducing apoptosis through the up-regulation of p53 and Bax, and down-regulation of Bcl-2.Eurycomanone has anti-cancer activity, inhibits A549 lung cancer cell proliferation in a dose-dependent manner at concentrations ranging from 5 to 20 μg ml.
  • Inquiry Price
Size
QTY
Allomatrine
T6S1010641-39-4
Lumichrome is an endogenous compound in humans, produced by photodegradation of riboflavin. It utilizes a p53-dependent mechanism to inhibit growth and induce apoptosis in human lung cancer cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Isoliquiritin
Neoisoliquritin
T5S03315041-81-6
1. Isoliquiritin (Neoisoliquritin) has antitussive effects. 2. Isoliquiritin has antidepressant-like effects. 3. Isoliquiritin, liquiritin and isoliquirigenin inhibits the p53-dependent pathway and shows crosstalk between Akt activities.
  • Inquiry Price
Size
QTY
Eriocalyxin B
TN162084745-95-9
Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways, should be considered a candidate for pancreatic cancer treatment; it is a specific inhibitor of STAT3, it directly target
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale